Merck & Co (NYSE: MRK)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 12/23/2022

Closing price: 111.86

Support price level:	$100.61
Resistance price level:	N/A
Relative strength index (14-day RSI)	57.2
Beta	0.37

MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
With a 47.7 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
MRK is one of this month's top performers with a return of 4.1 percent, beating 90 percent of stocks in the S&P-100.
The price of this low-beta stock is expected to increase by 0.37% for every 1% increase in the S&P-500.
MRK is one of this week's least volatile stocks in the S&P-100 with an estimated annualized standard deviation of 17.5%.
Volatility is forecast to fall over the next month.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$73.51	$111.86	100.0%

200 day	50 day	20 day	10 day
$92.01	$103.82	$109.98	$110.36

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
22.4%	21.5%	17.5%	20.3%

There is an estimated 5% probability that the stock price of Merck & Co will fall by more than: